INDEMNIFICATION AGREEMENTIndemnification Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of [ ], 2009, by and between Ironwood Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and [ ] (“Indemnitee”).
LICENSE AGREEMENT by and between IRONWOOD PHARMACEUTICALS, INC. and ASTELLAS PHARMA INC. November 10, 2009License Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) is entered into on this 10th day of November, 2009 (the “Effective Date”), by and among Ironwood Pharmaceuticals, Inc., a Delaware corporation (“Ironwood”) and Astellas Pharma Inc., a corporation organized under the laws of Japan (“Astellas”). Ironwood and Astellas may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT by and between IRONWOOD PHARMACEUTICALS, INC. and LABORATORIOS ALMIRALL, S.A. April 30, 2009License Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”) is entered into on this 30th day of April, 2009 (the “Effective Date”), by and among Ironwood Pharmaceuticals, Inc., a Delaware corporation (“Ironwood”) and Laboratorios Almirall, S.A., a corporation organized under the laws of Spain (“Partner”). Ironwood and Partner may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
COLLABORATION AGREEMENTMaster Collaboration Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • New York
Type of Securities: 2,083,334 shares of the Company’s common stock, at $12.00 per share, as may be adjusted pursuant to Section 5.2.2 of the Collaboration Agreement dated September 12, 2007, by and between the Company and the Purchaser, the “Collaboration Agreement”).
MICROBIA, INC.Ironwood Pharmaceuticals Inc • December 23rd, 2009 • Pharmaceutical preparations • Massachusetts
MICROBIA, INC. TERMS OF AMENDED AND RESTATED LEASE 320 BENT STREET, CAMBRIDGE, MAIronwood Pharmaceuticals Inc • December 23rd, 2009 • Pharmaceutical preparations • Massachusetts
CONSULTING AGREEMENTConsulting Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS CONSULTING AGREEMENT (together with its Business Terms Exhibit, the “Agreement”) made as of November 30, 2009 (the “Effective Date”) is between Ironwood Pharmaceuticals, Inc., a Delaware corporation having an address at 320 Bent Street, Cambridge, MA 02141 (“Ironwood”), and Christopher T. Walsh, Ph.D., having an address at 90 Baxter Road, Brookline, MA 02445 (tel: 617-432-1715) (“Consultant”). Ironwood desires to have the benefit of Consultant’s knowledge and experience, and Consultant desires to provide Consulting Services (defined below) to Ironwood, all as provided in this Agreement.
MASTER SECURITY AGREEMENT No. 8081150 Dated as of January 16, 2009 (“Agreement”)Master Security Agreement • December 23rd, 2009 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations • Virginia
THIS AGREEMENT is among Oxford Finance Corporation (together with its successors and assigns, if any, “Secured Party”) and Ironwood Pharmaceuticals, Inc. (“Ironwood”) and Microbia, Inc. (“Microbia”) (Ironwood and Microbia are jointly and severally, individually and collectively, the “Debtor”). Secured Party has an office at 133 N. Fairfax Street, Alexandria, VA 22314. Debtor is a corporation organized and existing under the laws of the state of Delaware. Ironwood’s mailing address and chief place of business is 320 Bent Street Cambridge, MA 02141. Microbia’s mailing address and chief place of business is 60 Westview Street Lexington, MA 02421.
